Sanofi to buy Blueprint Medicines in deal worth more than $9 billion statnews.com Nawigacja wpisu Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology – Yahoo Finance Complementary & Alternative Medicine for Anti Aging & – GlobeNewswire